MedPath

Effects of Food Cooking on Diabetes-2 Risk Factors

Not Applicable
Completed
Conditions
Obesity
Type 2 Diabetes
Insulin Resistance
Cardiovascular Disease
Interventions
Other: Dietary intervention
Registration Number
NCT01617304
Lead Sponsor
University of Copenhagen
Brief Summary

The aim of the project is to investigate the effects of advanced glycation end products (AGEs) formed in food during the cooking process as well as AGEs formed naturally in the human body, on insulin sensitivity and risk factors for type 2 diabetes. The hypothesis is that i) food content of AGEs is lower using boiling and steaming cooking methods and that ii) AGEs formation in the body is lower at low dietary intake of certain sugar forms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • women, healthy between 20 and 50 y
  • BMI between 25 and 40 kg/m2
  • weight circumference over 88 cm
Exclusion Criteria
  • weigh changes within the last 2 months more than +/- 3 kg
  • Physical activity more than 8 h per week
  • smoking
  • medications and supplements
  • being vegetarian or vegan
  • pregnancy or breast feeding
  • postmenopause
  • chronic disease
  • previous gastric bypass surgery
  • blood donation within the last 3 months
  • Involvement in other clinical trials
  • allergic to paraaminobenzoic acid

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
high AGE, fructoseDietary interventionFood prepared by frying/baking and 20 g of fructose 3 times a day in a water solution
low AGE, glucoseDietary interventionFood prepared by boiling/steaming and 20 g of glucose 3 times a day in a water solution
low AGE, fructoseDietary interventionFood prepared by boiling/steaming and 20 g of fructose 3 times a day in a water solution
high AGE, glucoseDietary interventionFood prepared by frying/baking and 20 g of glucose 3 times a day in a water solution
Primary Outcome Measures
NameTimeMethod
change in HOMA from baseline to 4 weeks0 and 4 weeks

insulin sensitivity

change in OGTT from baseline to 4 weeks0 and 4 weeks at 0 and 120 min

insulin sensitivity

change in appetite hormones (leptin, adiponectin, GLP-1, glukagon, ghrelin) from baseline to 4 weeks0 and 4 weeks
change in plasma and urin AGEs from baseline to 4 weeks0 and 4 weeks
change in immune response (CRP, C-peptide, IL-1B, IL-6, VCAM, ICAM, MIF, TNF-a, buffycoat) from baseline to 4 weeks0 and 4 weeks
change in metabolomics dats from baseline to 4 weeks0 and 4 weeks
change in AGE levels in skin from baseline to 4 weeks0 and 4 weeks
Secondary Outcome Measures
NameTimeMethod
change in HbA1c from baseline to 4 weeks0 and 4 weeks
change in lipid profile (TG, Chol, LDL, HDL, ox LDL, glycated LDL, fattyacids)from baseline to 4 weeks0 and 4 weeks

Trial Locations

Locations (1)

Department of Human Nutrition, University of Copenhagen

🇩🇰

Frederiksberg, Denmark

© Copyright 2025. All Rights Reserved by MedPath